SevenBridge Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.89M Buy
6,555
+74
+1% +$35.5K 0.57% 54
2026
Q1
$3.33M Buy
6,481
+364
+6% +$198K 0.52% 64
2025
Q4
$3.83M Buy
6,117
+83
+1% +$46.9K 0.62% 52
2025
Q3
$3.55M Buy
6,034
+1,079
+22% +$502K 0.58% 61
2025
Q2
$2.37M Buy
4,955
+1,371
+38% +$573K 0.42% 80
2025
Q1
$1.55M Buy
3,584
+1,674
+88% +$907K 0.31% 100
2024
Q4
$1.04M Buy
1,910
+959
+101% +$527K 0.2% 108
2024
Q3
$520K Buy
951
+152
+19% +$90K 0.1% 139
2024
Q2
$481K Buy
799
+349
+78% +$200K 0.11% 136
2024
Q1
$258K Buy
+450
New +$253K 0.06% 178
2018
Q4
Sell
-175
Closed -$43K 604
2018
Q3
$43K Buy
+175
New +$40.3K 0.02% 254

Other funds holding TMO

SevenBridge Financial Group's TMO Position: Q2 2026 in Review

SevenBridge Financial Group increased its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2026, buying an estimated $35.5K and bringing the position to 6,555 shares worth $3.89M. The position accounts for 0.57% of the portfolio, ranked #54.

SevenBridge Financial Group first reported a position in TMO in Q3 2018 and has held it in 11 quarters since. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • SevenBridge Financial Group held 6,555 shares of Thermo Fisher Scientific worth $3.89M as of Q2 2026.
  • SevenBridge Financial Group bought 74 Thermo Fisher Scientific shares in Q2 2026, an estimated $35.5K.
  • Thermo Fisher Scientific made up 0.57% of SevenBridge Financial Group's portfolio in Q2 2026, its #54 holding.
  • SevenBridge Financial Group first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 11 quarters since.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on SevenBridge Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.